Clicky

PolyPeptide Group AG(PPGN)

Description: PolyPeptide Group AG operate as a contract development and manufacturing company worldwide. It focuses on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development, and in generic products. It engages in manufacturing custom research grade peptides; and developing neoantigen peptide to support personalized cancer therapies. The company is also involved in manufacturing peptides for commercially approved peptide therapeutics. In addition, it manufactures peptide-based generics for human and veterinary markets; and cosmetic peptides. Further, the company offers regulatory affair support services. The company was founded in 1952 and is headquartered in Zug, Switzerland. PolyPeptide Group AG is a subsidiary of Draupnir Holding B.V.


Keywords: Pharmaceutical Products Peptide Cancer Therapies Pharmaceutical And Biotech Generic Products Personalized Cancer

Home Page: www.polypeptide.com

Dammstrasse 19
Zug, 6300
Switzerland
Phone: 41 41 723 20 34


Officers

Name Title
Dr. Raymond De Vre Ph.D. Chief Exec. Officer
Mr. Jan Fuhr Miller Chief Financial Officer
Mr. Daniel Lasanow Director of Global Operations
Mr. Michael Staheli Head of Investor Relations & Corp. Communications
Ms. Christina Del Vecchio Gen. Counsel & Corp. Sec.
Mr. Neil James Thompson Director of Global Sales & Marketing
Monika Casanova Chief HR Officer
Mr. Jan Christensen Exec. Officer

Exchange: SW

Country: CH

Currency: Swiss Franc (CHF)

Forward PE: 22.6757
Trailing PE: 28.3093
Price-to-Book MRQ: 1.9024
Price-to-Sales TTM: 2.822
IPO Date:
Fiscal Year End: December
Full Time Employees: 1156
Back to stocks